Core Scientific, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $0 | $8.7M |
| FY2021 | — | $1.34B | $117.9M |
| FY2022 | — | $-409.3M | $15.9M |
| FY2023 | — | $-596.9M | $50.4M |
| FY2024 | — | $-1.18B | $836.2M |
| FY2025 | — | $-962.7M | $311.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $0 | $8.7M |
| FY2021 | — | $1.34B | $117.9M |
| FY2022 | — | $-409.3M | $15.9M |
| FY2023 | — | $-596.9M | $50.4M |
| FY2024 | — | $-1.18B | $836.2M |
| FY2025 | — | $-962.7M | $311.4M |